Pharma Journalist - Page 48 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Illumina Protein Prep Launches to Boost Proteomic Insights for Drug Discovery

Amgen to Invest Over $600 Million in New Science and Innovation Center at U.S. Headquarters

Quotient Sciences and CPI Launch Joint Venture to Speed Up RNA Drug Development

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, NJ Site

OMass Therapeutics Partners with Genentech to Develop Inflammatory Bowel Disease Therapies

FDA Approves Henlius and Organon’s BILDYOS and BILPREVDA Biosimilars to PROLIA and XGEVA

Boehringer’s HERNEXEOS Approved in China as First Oral Targeted Therapy for HER2-Mutant Advanced NSCLC

FDA Approves LEQEMBI IQLIK Subcutaneous Injection for Early Alzheimer’s Maintenance Therapy

Santhera Partners with Ikris Pharma Network to Distribute AGAMREE in India

Sanofi’s Wayrilz Approved in US as First BTK Inhibitor for Immune Thrombocytopenia